Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-01-01 @ 1:44 PM
Study NCT ID:
NCT03918304
Status:
COMPLETED
Last Update Posted:
2025-10-23
First Post:
2019-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-15
First Submit QC Date:
None
Study First Post Date:
2019-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-22
Last Update Post Date:
2025-10-23
Last Update Post Date Type:
ESTIMATED